NCT02445274

Brief Summary

In this study, the investigators introduce a new "capsule-reserved" cataract surgical procedure in which anterior lens capsule is reserved and attached onto posterior lens capsule in the purpose of preventing posterior capsule opacification (PCO). A prospective randomized controlled study is reported to compare the new "capsule-reserved" surgical procedure with conventional one on the effectiveness to prevent posterior capsule opacification in age-related cataract patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
240

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2015

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2015

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

May 4, 2015

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 15, 2015

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
Last Updated

May 3, 2016

Status Verified

April 1, 2016

Enrollment Period

1.3 years

First QC Date

May 4, 2015

Last Update Submit

April 29, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from Baseline in posterior capsule opacification grading score

    Posterior capsule opacification(PCO)was recorded by standardized slit lamp retroillumination images and analyzed using the EPCO2000 program. The severity of PCO was clinically graded from 0 (none) to 4 (severe)

    post-operative day 1, post-operative week 1, post-operative month 1, post-operative month 3,

Secondary Outcomes (2)

  • Change from Baseline in central posterior capsule thickness

    post-operative day 1, post-operative week 1, post-operative month 1, post-operative month 3, post-operative month 6, post-operative year 1

  • Change from Baseline in central posterior capsule density

    post-operative day 1, post-operative week 1, post-operative month 1, post-operative month 3, post-operative month 6, post-operative year 1

Other Outcomes (2)

  • Change from Baseline in best corrected visual acuity

    post-operative day 1, post-operative week 1, post-operative month 1, post-operative month 3, post-operative month 6, post-operative year 1

  • Change from Baseline in contrast sensitivity

    post-operative day 1, post-operative week 1, post-operative month 1, post-operative month 3, post-operative month 6, post-operative year 1

Study Arms (2)

Capsule-reserved surgical procedure

EXPERIMENTAL

In this group, the anterior lens capsule was reserved after continuous curvilinear capsulorhexis. The reserved anterior capsule was pressed flattened by the optical surface of the IOL and attached onto the posterior lens capsule. Phacoemulsification was performed with the same device and handpieces, using the same phaco chop technique as in the conventional procedure group.

Procedure: Anterior lens capsule was reserved

Conventional surgical procedure

NO INTERVENTION

In this group, the anterior lens capsule was not reserved or attached onto the posterior lens capsule.

Interventions

The anterior lens capsule was reserved after continuous curvilinear capsulorhexis. The reserved anterior capsule was pressed flattened by the optical surface of the IOL and attached onto the posterior lens capsule.

Capsule-reserved surgical procedure

Eligibility Criteria

Age50 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 50 years or above
  • Both eyes were diagnosed with age-related cataract
  • Both eyes were planed to undergo the "Phacoemulsification and IOL implantation" surgery with 1 month
  • Biocular BCVA improvement post surgery was feasible judged by the ophthalmologists.

You may not qualify if:

  • Other ocular diseases
  • ACD\<3CT
  • Combined cataract surgery (trabeculoplasty, keratoplasty)
  • Lens pseudoexfoliation syndrome combined with glaucoma or zonular abnormalities
  • Previous intraocular surgery or trauma (laser not included)
  • Uveitis
  • Recent ocular infection
  • Proliferative diabetic retinopathy
  • Diabetes mellitus
  • Congenital ocular abnormalities (aniridia, congenital cataract)
  • Atrophy of iris
  • Participants with previous clinical trials 30 days before surgery
  • Using prostanoid eye drops
  • Uncontrolled systematic diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhognshan Ophthalmic Center, Sun Yat-sen University

Guangzhou, Guangdong, 510060, China

RECRUITING

Related Publications (4)

  • Luo L, Lin H, Chen W, Qu B, Zhang X, Lin Z, Chen J, Liu Y. Intraocular lens-shell technique: adjustment of the surgical procedure leads to greater safety when treating dense nuclear cataracts. PLoS One. 2014 Nov 17;9(11):e112663. doi: 10.1371/journal.pone.0112663. eCollection 2014.

    PMID: 25401512BACKGROUND
  • Lin H, Yan P, Yu K, Luo L, Chen J, Lin Z, Chen W. Anterior segment variations after posterior chamber phakic intraocular lens implantation in myopic eyes. J Cataract Refract Surg. 2013 May;39(5):730-8. doi: 10.1016/j.jcrs.2012.12.026. Epub 2013 Mar 14.

    PMID: 23499067BACKGROUND
  • Lin HT, Chen WR, Ding ZF, Chen W, Wu CR. Clinical evaluation of two multifocal intraocular lens implantation patterns. Int J Ophthalmol. 2012;5(1):76-83. doi: 10.3980/j.issn.2222-3959.2012.01.16. Epub 2012 Feb 18.

    PMID: 22553760BACKGROUND
  • Luo L, Lin H, He M, Congdon N, Yang Y, Liu Y. Clinical evaluation of three incision size-dependent phacoemulsification systems. Am J Ophthalmol. 2012 May;153(5):831-839.e2. doi: 10.1016/j.ajo.2011.10.034. Epub 2012 Feb 4.

Related Links

MeSH Terms

Conditions

Cataract

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Study Officials

  • Yizhi Liu, M.D., PhD

    Zhongshan Ophthalmic Center, Sun Yat-sen University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Haotian Lin, M.D., PhD

CONTACT

Xiaohang Wu, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 4, 2015

First Posted

May 15, 2015

Study Start

May 1, 2015

Primary Completion

August 1, 2016

Study Completion

August 1, 2016

Last Updated

May 3, 2016

Record last verified: 2016-04

Locations